StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3099% above fair value
$144.67−3.69 (-2.49%)

Close on Nov 3, 2026Market cap $356.93BP/E 149.1Yield 2.27%

Merck Animal Health by Quarter

Animal Health — Companion Animal (vaccines & parasiticides) — International sales ($M) ($M)

QuarterlyAnnual

Merck Animal Health: $402M in Q2 2026, up 6.9% from a year earlier.

Latest, Q2 2026
402
Period ended Jun 30, 2026
Change on a year earlier
+6.9%
376 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
34
Documents cited below

Where the Q2 2026 figure comes from

“|| Companion Animal | 734 | 685 | 7 | 333 | 309 | 8 | 402 | 376 | 7”

Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Segment & Product Sales Footnote & Form 8-K Table 3 / 3a / 3b.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAnimal Health — Companion Animal (vaccines & parasiticides) — International sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026402+6.9%Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q1 2026Mar 31, 2026419+17.7%Form 10-Q (filed 2026-05-04) ↗
Q4 2025Dec 31, 2025279+4.5%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q3 2025Sep 30, 2025301-2.0%Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗
Q2 2025Jun 30, 2025376+5.0%Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q1 2025Mar 31, 2025356+0.6%Form 8-K (tm2512885d1_ex99-1.htm, filed 2025-04-24) ↗
Q4 2024Dec 31, 2024267+10.3%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q3 2024Sep 30, 2024307+14.1%Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗
Q2 2024Jun 30, 2024358+5.6%Form 8-K (tm2521736d1_ex99-1.htm, filed 2025-07-29) ↗
Q1 2024Mar 31, 2024354+6.0%Form 8-K (tm2512885d1_ex99-1.htm, filed 2025-04-24) ↗
Q4 2023Dec 31, 2023242+16.3%Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
Q3 2023Sep 30, 2023269+6.3%Form 8-K (tm2426878d1_ex99-1.htm, filed 2024-10-31) ↗
Q2 2023Jun 30, 2023339+3.4%Form 8-K (tm2420272d1_ex99-1.htm, filed 2024-07-30) ↗
Q1 2023Mar 31, 2023334-4.0%Form 8-K (tm2412490d1_ex99-1.htm, filed 2024-04-25) ↗
Q4 2022Dec 31, 2022208-11.1%Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
Q3 2022Sep 30, 2022253-8.3%Form 8-K (tm2328962d1_ex99-1.htm, filed 2023-10-26) ↗

Breakdown

What makes up animal Health

Cite this data

StockData. (2026). Merck Animal Health ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-ah-companion-intl

See every metric in the Merck KPI table. Data updated Oct 26, 2026.

See a number that looks wrong?